Furthermore, cells just undergoing CD271-mediated phenotype switching are conceivably rare in the tumor bulk16, which could account for the very limited overlap between the CD271-controlled gene expression program and the MITF and AXL programs derived from human patient biopsies35. The gene discussed is NGFR; the disease is neoplasm.